Sorry boys I'm putting all you bashers and responders to bashers on ignore.
I've done my DD. I'm responsible for my own investment decisions.
The markets cares if the Glycomim is cutting edge, and it seems to be. The market cares Whether it works...and first indication in trials is it does work. The market cares if it has financial support and it seems the French government is behind it judging from initial grants from the government....and maybe new grants can be obtained.
The ignore button is going to work. Too much of my time is wasted reading the same old same old.